• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗德黑兰多发性硬化症的患病率和发病率

Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.

作者信息

Eskandarieh Sharareh, Heydarpour Pouria, Elhami Seyedeh-Robab, Sahraian Mohammad Ali

机构信息

Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Public Health. 2017 May;46(5):699-704.

PMID:28560202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5442284/
Abstract

BACKGROUND

Tehran is the capital of Iran with an increasing Multiple Sclerosis (MS) incidence. A retrospective population-based study was conducted to evaluate the status of MS prevalence and MS incidence trends in Tehran Province, Iran.

METHODS

A population-based study was conducted from 1991 to 2014 in Tehran Province, the capital city of Iran based on Iranian MS Society (IMSS) registry system. A structured questionnaire design to cover the important epidemiological variables, related at the individual level for MS. A Monte Carlo Permutation method was utilized to test whether the apparent change in MS trends during 1991-2014 was statistically significant.

RESULTS

MS incidence was significantly increased during our study period. The annual percent change (APC) was 12.8% in women during 1991 to 2004 and 12.5% in men during the same period. The point prevalence of MS was 101.39 per 100000 populations in 2014. The age-adjusted prevalence rates were 134.03 and for male patients were 42.45 per 100000.

CONCLUSION

MS prevalence and incidence in Tehran are markedly rising, it is crucial to elucidate the causes of the increasing trends and implement efficient policies lowering disease burden.

摘要

背景

德黑兰是伊朗首都,多发性硬化症(MS)发病率呈上升趋势。开展了一项基于人群的回顾性研究,以评估伊朗德黑兰省MS患病率及发病趋势情况。

方法

1991年至2014年在伊朗首都德黑兰省基于伊朗多发性硬化症协会(IMSS)登记系统开展了一项基于人群的研究。设计了一份结构化问卷,涵盖与MS个体层面相关的重要流行病学变量。采用蒙特卡洛排列法检验1991 - 2014年期间MS趋势的明显变化是否具有统计学意义。

结果

在我们的研究期间,MS发病率显著增加。1991年至2004年期间,女性的年变化百分比(APC)为12.8%,同期男性为12.5%。2014年MS的点患病率为每10万人口101.39例。年龄调整后的患病率为每10万人口134.03例,男性患者为42.45例。

结论

德黑兰的MS患病率和发病率显著上升,阐明上升趋势的原因并实施有效政策降低疾病负担至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e07d/5442284/6d74e427d9c6/IJPH-46-699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e07d/5442284/6d74e427d9c6/IJPH-46-699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e07d/5442284/6d74e427d9c6/IJPH-46-699-g001.jpg

相似文献

1
Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.伊朗德黑兰多发性硬化症的患病率和发病率
Iran J Public Health. 2017 May;46(5):699-704.
2
Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.伊朗多发性硬化症家族复发患病率上升:基于德黑兰1999 - 2015年登记处的一项人群研究。
BMC Neurol. 2018 Feb 7;18(1):15. doi: 10.1186/s12883-018-1019-2.
3
A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.伊朗德黑兰多发性硬化症的 20 年发病趋势(1989-2008 年)和时点患病率(2009 年 3 月 20 日):一项基于人群的研究。
Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20.
4
Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.多发性硬化症患病率增加的证据:1999-2018 年德黑兰注册中心的一项基于人群的研究。
BMC Neurol. 2020 May 2;20(1):169. doi: 10.1186/s12883-020-01747-8.
5
Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?德黑兰的多发性硬化症:发病率稳定的同时患病率上升——是真实增长还是诊断水平提高?
Arch Iran Med. 2019 Aug 1;22(8):429-434.
6
Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999-2018.家族性多发性硬化症的流行病学:1999年至2018年在德黑兰开展的一项基于人群的研究。
Mult Scler Relat Disord. 2020 Aug;43:102178. doi: 10.1016/j.msard.2020.102178. Epub 2020 May 14.
7
Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.伊朗马尔卡齐省多发性硬化症的时间发病率和患病率趋势
Mult Scler Relat Disord. 2022 Apr;60:103691. doi: 10.1016/j.msard.2022.103691. Epub 2022 Feb 22.
8
The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.2021年伊朗德黑兰原发性和家族性多发性硬化症的发病率及患病率。
Neurol Sci. 2023 Dec;44(12):4517-4518. doi: 10.1007/s10072-023-07043-w. Epub 2023 Aug 29.
9
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症发病率和患病率急剧上升。
Mult Scler. 2011 Aug;17(8):1022-7. doi: 10.1177/1352458511401460. Epub 2011 Apr 1.
10
Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: A case-control study.多发性硬化症与视神经脊髓炎的流行病学及基线特征比较:一项病例对照研究。
Mult Scler Relat Disord. 2017 Feb;12:39-43. doi: 10.1016/j.msard.2017.01.004. Epub 2017 Jan 6.

引用本文的文献

1
Prevalence of Multiple Sclerosis in Vitiligo Patients and Their First-Degree Relatives: Two Diseases with Similarities in Pathogenesis and Treatment.白癜风患者及其一级亲属中多发性硬化症的患病率:两种在发病机制和治疗方面具有相似性的疾病。
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024103. doi: 10.5826/dpc.1403a103.
2
Impact of Alcohol Consumption on Multiple Sclerosis Using Model-based Standardization and Misclassification Adjustment Via Probabilistic Bias Analysis.基于模型标准化和概率偏差分析的校正方法,探究饮酒对多发性硬化症的影响。
Arch Iran Med. 2023 Oct 1;26(10):567-574. doi: 10.34172/aim.2023.83.
3
Evaluation of safety of rituximab in patients with multiple sclerosis: A retrograde study.

本文引用的文献

1
Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis.中东和北非地区的多发性硬化症流行病学:系统评价与荟萃分析
Neuroepidemiology. 2015;44(4):232-44. doi: 10.1159/000431042. Epub 2015 Jun 16.
2
Estimated prevalence and incidence of multiple sclerosis in Iran.伊朗多发性硬化症的估计患病率和发病率。
Eur Neurol. 2014;72(5-6):370-4. doi: 10.1159/000365846. Epub 2014 Oct 18.
3
Is it time for a new global classification of multiple sclerosis?是时候进行多发性硬化症的新全球分类了吗?
利妥昔单抗治疗多发性硬化症患者的安全性评估:一项回顾性研究。
Curr J Neurol. 2020 Jul 5;19(3):103-106. doi: 10.18502/cjn.v19i3.5422.
4
Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran.在伊朗,克拉屈滨片对于高疾病活动度复发型多发性硬化症患者而言是一种具有成本效益的治疗策略。
Curr J Neurol. 2021 Jul 6;20(3):146-153. doi: 10.18502/cjn.v20i3.7690.
5
Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models.与多发性硬化症诊断延迟月数相关的因素:计数回归模型的比较
Curr J Neurol. 2023 Apr 4;22(2):65-71. doi: 10.18502/cjn.v22i2.13330.
6
A randomized controlled trial investigating the effects of a mediterranean-like diet in patients with multiple sclerosis-associated cognitive impairments and fatigue.一项随机对照试验,研究类似地中海饮食对多发性硬化症相关认知障碍和疲劳患者的影响。
Curr J Neurol. 2020 Jul 5;19(3):112-121. doi: 10.18502/cjn.v19i3.5424.
7
The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021.2021年伊朗德黑兰原发性和家族性多发性硬化症的发病率及患病率。
Neurol Sci. 2023 Dec;44(12):4517-4518. doi: 10.1007/s10072-023-07043-w. Epub 2023 Aug 29.
8
How does multiple sclerosis affect sexual satisfaction in patients' spouses?多发性硬化症如何影响患者配偶的性满意度?
Front Psychol. 2023 Apr 4;14:1110884. doi: 10.3389/fpsyg.2023.1110884. eCollection 2023.
9
Increasing Incidence and Male to Female Sex Ratio of Multiple Sclerosis in Tehran, Iran: A Population-Based Study.伊朗德黑兰多发性硬化症发病率上升及男女比例变化:一项基于人群的研究
Iran J Public Health. 2022 May;51(5):1193-1194. doi: 10.18502/ijph.v51i5.9439.
10
The and Variants are Associated with Multiple Sclerosis: A Study on Iranian Population.[此处原文不完整,缺失具体的基因等相关信息]和[此处原文不完整,缺失具体的基因等相关信息]变体与多发性硬化症相关:对伊朗人群的一项研究
Iran J Biotechnol. 2022 Jul 1;20(3):e3012. doi: 10.30498/ijb.2022.276921.3012. eCollection 2022 Jul.
J Neurol Sci. 2014 Sep 15;344(1-2):171-81. doi: 10.1016/j.jns.2014.06.051. Epub 2014 Jun 29.
4
Epidemiology of multiple sclerosis in Qom: Demographic study in Iran.库姆地区多发性硬化症的流行病学:伊朗的人口统计学研究。
Iran J Neurol. 2013;12(4):136-43.
5
Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis.伊朗德黑兰的多发性硬化症:连接点趋势分析
Mult Scler. 2014 Apr;20(4):512. doi: 10.1177/1352458513494496. Epub 2013 Jul 8.
6
Risk factors for multiple sclerosis in Kuwait: a population-based case-control study.科威特多发性硬化症的风险因素:一项基于人群的病例对照研究。
Neuroepidemiology. 2013;40(1):30-5. doi: 10.1159/000341240. Epub 2012 Oct 11.
7
Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar.卡塔尔多发性硬化症的患病率、人口统计学特征及临床特点
Mult Scler. 2013 May;19(6):816-9. doi: 10.1177/1352458512459291. Epub 2012 Sep 11.
8
Incidence and prevalence of multiple sclerosis in southeastern Iran.伊朗东南部多发性硬化症的发病率和患病率
Clin Neurol Neurosurg. 2013 Mar;115(3):304-8. doi: 10.1016/j.clineuro.2012.05.032. Epub 2012 Jun 18.
9
A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.伊朗德黑兰多发性硬化症的 20 年发病趋势(1989-2008 年)和时点患病率(2009 年 3 月 20 日):一项基于人群的研究。
Neuroepidemiology. 2011;36(3):141-7. doi: 10.1159/000324708. Epub 2011 Apr 20.
10
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.伊朗伊斯法罕多发性硬化症发病率和患病率急剧上升。
Mult Scler. 2011 Aug;17(8):1022-7. doi: 10.1177/1352458511401460. Epub 2011 Apr 1.